Prosecution Insights
Last updated: July 17, 2026
Application No. 17/956,141

CLINICAL OMICS DATA PROCESSING METHOD AND APPARATUS BASED ON GRAPH NEURAL NETWORK, DEVICE AND MEDIUM

Non-Final OA
Filed
Sep 29, 2022
Priority
Nov 30, 2020 — CN 202011379315.3 +1 more
Examiner
ELKINS, BLAKE HARRISON
Art Unit
1687
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Tencent Technology (Shenzhen) Company Limited
OA Round
1 (Non-Final)
100%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 100% — above average
100%
Career Allowance Rate
1 granted / 1 resolved
+40.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
16 currently pending
Career history
19
Total Applications
across all art units

Statute-Specific Performance

§103
8.8%
-31.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1 resolved cases

Prosecution Timeline

Sep 29, 2022
Application Filed
Apr 20, 2026
Non-Final Rejection mailed (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
100%
Grant Probability
99%
With Interview (+0.0%)
4y 1m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month